September 2019

Abstract 14: Naloxone Prescriptions Among Commercially Insured Individuals

EMA 2019 September29 Chapters

  1. Introduction6:43
  2. Ultra Summary24:34
  3. Rick’s Rants: Our Prices Are Too High17:11
  4. Time To Talk A Little Nerdy: Statistical Significance17:48
  5. Reflections of a Skeptic: EBM Part I20:16
  6. Then And Now: Saline vs. Balanced Solutions Again!19:41
  7. Farewell2:02
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Adam M. -

There seems to be a major undiscussed flaw with this paper: it's based on insurance claims data. Correct me if I'm wrong, but an insurance claim isn't filed when a doctor PRESCRIBES a medication, but only when a patient FILLS that prescription.

I prescribe naloxone nasal spray often, and I know many of my colleagues do also. Every time after an OD, and for many more who are high risk. Hopefully we also spend time discussing naloxone with these patients and why it's so important. But whether or not a patient acts on these recommendations is ultimately out of our hands.

Our ED provides patients with hard-copy prescriptions they can take to any pharmacy. For every 10 or 20 naloxone scripts I write, I'm hoping that at least one patient will actually fill the script and receive the med.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.